Interesting that in this [ag-biotech] space there is a 6-year product development cycle.
It’s more similar to the drug-development cycle than many investors realize. Projects are designated phase-1, phase-2, phase-3, and phase-4, with the designations being roughly similar to the those in drug development.
E.g., here’s MON’s pipeline update from Jan 2013: #msg-83244701.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.